Search Results - "TADOKORO, TOMOKO"

Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA by Tadokoro, Tomoko, Morishita, Asahiro, Masaki, Tsutomu

“…Remarkable progress has been made in the treatment and control of hepatitis B and C viral infections. However, fundamental treatments for diseases in which…”
Get full text

MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review by Morishita, Asahiro, Oura, Kyoko, Tadokoro, Tomoko, Fujita, Koji, Tani, Joji, Masaki, Tsutomu

“…Hepatocellular carcinoma (HCC) is the seventh most frequent cancer and the fourth leading cause of cancer mortality worldwide. Despite substantial advances in…”
Get full text

Nutritional Support for Alcoholic Liver Disease by Tadokoro, Tomoko, Morishita, Asahiro, Himoto, Takashi, Masaki, Tsutomu

“…Malnutrition is a common finding in alcohol use disorders and is associated with the prognosis of patients with alcoholic liver disease (ALD). These patients…”
Get full text

MicroRNA Interference in Hepatic Host-Pathogen Interactions by Morishita, Asahiro, Oura, Kyoko, Tadokoro, Tomoko, Fujita, Koji, Tani, Joji, Masaki, Tsutomu

“…The liver is well recognized as a non-immunological visceral organ that is involved in various metabolic activities, nutrient storage, and detoxification…”
Get full text

Ledipasvir/Sofosbuvir Is Effective for Relapsed Genotype 1b Hepatitis C Virus Patients after Achieving a Sustained Virological Response at Post-treatment Week 12 with Glecaprevir/Pibrentasvir by Manabe, Takushi, Tadokoro, Tomoko, Nakahara, Mai, Ohura, Kyoko, Fujita, Koji, Tani, Joji, Morishita, Asahiro, Ogawa, Chikara, Masaki, Tsutomu

“…A patient with genotype 1b chronic hepatitis C virus who had been treated with pegylated interferon and ribavirin (RBV) was treated with…”
Get full text

MicroRNAs and Nonalcoholic Steatohepatitis: A Review by Morishita, Asahiro, Oura, Kyoko, Tadokoro, Tomoko, Fujita, Koji, Tani, Joji, Kobara, Hideki, Ono, Masafumi, Himoto, Takashi, Masaki, Tsutomu

“…Non-alcoholic fatty liver disease (NAFLD) is a clinicopathologic syndrome caused by fat deposition in hepatocytes. Patients with nonalcoholic steatohepatitis…”
Get full text

Galectin-9 in Gastroenterological Cancer by Morishita, Asahiro, Oura, Kyoko, Tadokoro, Tomoko, Shi, Tingting, Fujita, Koji, Tani, Joji, Atsukawa, Masanori, Masaki, Tsutomu

“…Immunochemotherapy has become popular in recent years. The detailed mechanisms of cancer immunity are being elucidated, and new developments are expected in…”
Get full text

Effectiveness of edoxaban in portal vein thrombosis associated with liver cirrhosis by Tadokoro, Tomoko, Tani, Joji, Manabe, Takushi, Takuma, Kei, Nakahara, Mai, Oura, Kyoko, Mimura, Shima, Fujita, Koji, Nomura, Takako, Morishita, Asahiro, Kobara, Hideki, Himoto, Takashi, Ono, Masafumi, Masaki, Tsutomu

“…Portal vein thrombosis (PVT) worsens the long-term prognosis of patients with cirrhosis; however, the optimal treatment remains to be determined. Reports on…”
Get full text

Ipragliflozin attenuates non-alcoholic steatohepatitis development in an animal model by Morishita, Asahiro, Tadokoro, Tomoko, Fujihara, Shintaro, Iwama, Hisakazu, Oura, Kyoko, Fujita, Koji, Tani, Joji, Takuma, Kei, Nakahara, Mai, Shi, Tingting, Haba, Reiji, Okano, Keiichi, Nishiyama, Akira, Ono, Masafumi, Himoto, Takashi, Masaki, Tsutomu

“…Non-alcoholic steatohepatitis (NASH) is a common chronic liver disease with no decisive treatment. The sodium glucose cotransporter 2 (SGLT2) inhibitor…”
Get full text

Albumin–bilirubin score indicates liver fibrosis staging and prognosis in patients with chronic hepatitis C by Fujita, Koji, Oura, Kyoko, Yoneyama, Hirohito, Shi, Tingting, Takuma, Kei, Nakahara, Mai, Tadokoro, Tomoko, Nomura, Takako, Morishita, Asahiro, Tsutsui, Kunihiko, Himoto, Takashi, Masaki, Tsutomu

“…Aim Albumin–bilirubin (ALBI) grade was investigated to predict prognosis of patients with cirrhosis. It was defined using the ALBI score calculated based on…”
Get full text

Pemafibrate improves liver dysfunction and non-invasive surrogates for liver fibrosis in patients with non-alcoholic fatty liver disease with hypertriglyceridemia: a multicenter study by Morishita, Asahiro, Oura, Kyoko, Takuma, Kei, Nakahara, Mai, Tadokoro, Tomoko, Fujita, Koji, Tani, Joji, Shi, Tingting, Himoto, Takashi, Tatsuta, Miwa, Moriya, Akio, Senoo, Tomonori, Tsutsui, Akemi, Nagano, Takuya, Takaguchi, Koichi, Ono, Masafumi, Masaki, Tsutomu

“…Background This retrospective, multicenter study evaluated the effect of pemafibrate treatment on liver function and fibrosis by liver function tests (LFTs)…”
Get full text

A Case of Idiopathic Portal Hypertension Diagnosed by Noninvasive Fibrosis Evaluation Using Elastography by Yano, Rie, Tadokoro, Tomoko, Morishita, Asahiro, Ibuki, Emi, Masaki, Tsutomu

“…Idiopathic portal hypertension (IPH) is often misdiagnosed as liver cirrhosis. Because it is difficult to distinguish between the two using diagnostic imaging,…”
Get full text

Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest by Samukawa, Eri, Fujihara, Shintaro, Oura, Kyoko, Iwama, Hisakazu, Yamana, Yoshimi, Tadokoro, Tomoko, Chiyo, Taiga, Kobayashi, Kiyoyuki, Morishita, Asahiro, Nakahara, Mai, Kobara, Hideki, Mori, Hirohito, Okano, Keiichi, Suzuki, Yasuyuki, Himoto, Takashi, Masaki, Tsutomu

“…Cholangiocarcinoma (CCA) is at an advanced stage at the time of its diagnosis, and developing a more effective treatment of CCA would be desirable. Angiotensin…”
Get full text

Cancer Therapy Due to Apoptosis: Galectin-9 by Fujita, Koji, Iwama, Hisakazu, Oura, Kyoko, Tadokoro, Tomoko, Samukawa, Eri, Sakamoto, Teppei, Nomura, Takako, Tani, Joji, Yoneyama, Hirohito, Morishita, Asahiro, Himoto, Takashi, Hirashima, Mitsuomi, Masaki, Tsutomu

“…Dysregulation of apoptosis is a major hallmark in cancer biology that might equip tumors with a higher malignant potential and chemoresistance. The anti-cancer…”
Get full text

Management of hepatocellular carcinoma, an important cause of death in Japanese autoimmune hepatitis patients by Tadokoro, Tomoko, Nomura, Takako, Fujita, Koji, Manabe, Takushi, Takuma, Kei, Nakahara, Mai, Oura, Kyoko, Mimura, Shima, Tani, Joji, Morishita, Asahiro, Kobara, Hideki, Ono, Masafumi, Masaki, Tsutomu

“…Hepatocellular carcinoma (HCC) in autoimmune hepatitis (AIH) was considered rare but is increasing with prolonged prognosis. Its impact on the overall…”
Get full text

A Case of Chronic Hepatitis B in which HBs Antigen Seroclearance was Induced by Pegpegylated-interferonα-2a after Hepatocellular Carcinoma Treatment with Nucleos(t)ide Analogues: A Five-year Follow-up by Mimura, Shima, Ono, Masafumi, Fujita, Koji, Takuma, Kei, Nakahara, Mai, Oura, Kyoko, Tadokoro, Tomoko, Tani, Joji, Morishita, Asahiro, Kagawa, Seiko, Okano, Keiichi, Himoto, Takashi, Masaki, Tsutomu

“…We herein report a 40-year-old Japanese man with chronic hepatitis B genotype C (viral load 6.7 LC/mL) who developed hepatocellular carcinoma (HCC) despite…”
Get full text

Extrahepatic Cancer Risk in Patients with Hepatitis C Virus Infection Treated with Direct-Acting Antivirals by Tani, Joji, Masaki, Tsutomu, Oura, Kyoko, Tadokoro, Tomoko, Morishita, Asahiro, Kobara, Hideki

“…Chronic hepatitis C virus (HCV) infection is associated with an increased risk of extrahepatic cancers, particularly non-Hodgkin lymphoma. The introduction of…”
Get full text

Galectin-9 Induces Mitochondria-Mediated Apoptosis of Esophageal Cancer In Vitro and In Vivo in a Xenograft Mouse Model by Chiyo, Taiga, Fujita, Koji, Iwama, Hisakazu, Fujihara, Shintaro, Tadokoro, Tomoko, Ohura, Kyoko, Matsui, Takanori, Goda, Yasuhiro, Kobayashi, Nobuya, Nishiyama, Noriko, Yachida, Tatsuo, Morishita, Asahiro, Kobara, Hideki, Mori, Hirohito, Niki, Toshiro, Hirashima, Mitsuomi, Himoto, Takashi, Masaki, Tsutomu

“…Galectin-9 (Gal-9) enhances tumor immunity mediated by T cells, macrophages, and dendritic cells. Its expression level in various cancers correlates with…”
Get full text

Antitumor Effect of Regorafenib on MicroRNA Expression in Hepatocellular Carcinoma Cell Lines by Takuma, Kei, Fujihara, Shintaro, Fujita, Koji, Iwama, Hisakazu, Nakahara, Mai, Oura, Kyoko, Tadokoro, Tomoko, Mimura, Shima, Tani, Joji, Shi, Tingting, Morishita, Asahiro, Kobara, Hideki, Himoto, Takashi, Masaki, Tsutomu

“…Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and is one of the leading causes of cancer-related deaths worldwide…”
Get full text

Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest by Oura, Kyoko, Tadokoro, Tomoko, Fujihara, Shintaro, Morishita, Asahiro, Chiyo, Taiga, Samukawa, Eri, Yamana, Yoshimi, Fujita, Koji, Sakamoto, Teppei, Nomura, Takako, Yoneyama, Hirohito, Kobara, Hideki, Mori, Hirohito, Iwama, Hisakazu, Okano, Keiichi, Suzuki, Yasuyuki, Masaki, Tsutomu

“…Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and the third leading cause of cancer-related death. Telmisartan, a widely…”
Get full text